180 related articles for article (PubMed ID: 11131220)
1. Hyperthermic intraoperative intraperitoneal chemotherapy for peritoneal carcinomatosis and sarcomatosis using a cardioplegia heat exchanger and a two-pump system: a case report.
Vocelka CR; Anderson DL; Crockett GI
Perfusion; 2000 Nov; 15(6):549-52. PubMed ID: 11131220
[TBL] [Abstract][Full Text] [Related]
2. [Resectional treatment of peritoneal carcinomatosis followed by intraperitoneal chemotherapy, practical aspects].
Elias D; Lasser P; Reynard B; Ducreux M; Pocard M
J Chir (Paris); 2003 Oct; 140(5):270-6. PubMed ID: 14631291
[TBL] [Abstract][Full Text] [Related]
3. Patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, and role of laparoscopy in diagnosis, staging, and treatment.
Valle M; Federici O; Garofalo A
Surg Oncol Clin N Am; 2012 Oct; 21(4):515-31. PubMed ID: 23021713
[TBL] [Abstract][Full Text] [Related]
4. Anesthesia considerations during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Rothfield KP; Crowley K
Surg Oncol Clin N Am; 2012 Oct; 21(4):533-41. PubMed ID: 23021714
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a case report.
Rotruck S; Wilson JT; McGuire J
AANA J; 2014 Apr; 82(2):140-3. PubMed ID: 24902457
[TBL] [Abstract][Full Text] [Related]
6. [Clinical practice guideline on peritoneal carcinomatosis treatment using surgical cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy].
Kavanagh M; Ouellet JF;
Bull Cancer; 2006 Sep; 93(9):867-74. PubMed ID: 16980229
[TBL] [Abstract][Full Text] [Related]
7. Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients.
Rossi CR; Deraco M; De Simone M; Mocellin S; Pilati P; Foletto M; Cavaliere F; Kusamura S; Gronchi A; Lise M
Cancer; 2004 May; 100(9):1943-50. PubMed ID: 15112276
[TBL] [Abstract][Full Text] [Related]
8. Semi-closed hyperthermic-antiblastic peritoneal perfusion (HAPP) in the treatment of peritoneal carcinosis.
De Simone M; Barone R; Vaira M; Aghemo B; Mioli P; Franco C; Scuderi S; Costamagna D; Dei Poli M
J Surg Oncol; 2003 Feb; 82(2):138-40. PubMed ID: 12561072
[No Abstract] [Full Text] [Related]
9. Surgery and intracavitary chemotherapy for peritoneal carcinomatosis from colorectal origin.
Ceelen W; Van Nieuwenhove Y; Pattyn P
Acta Gastroenterol Belg; 2008; 71(4):373-8. PubMed ID: 19317277
[TBL] [Abstract][Full Text] [Related]
10. Lessons learnt from clinical trials in peritoneal surface oncology: colorectal carcinomatosis.
Zoetmulder FA; Verwaal VJ
Recent Results Cancer Res; 2007; 169():99-103. PubMed ID: 17506253
[No Abstract] [Full Text] [Related]
11. [Treatment of peritoneal carcinomatosis with surgery and hyperthermic peroperative intraperitoneal chemotherapy (HIPEC): new aspects and validated indications].
Eveno C; Dagois S; Guillot E; Gornet JM; Pocard M
Bull Cancer; 2008 Jan; 95(1):141-5. PubMed ID: 18230580
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer by extensive cytoreductive surgery combined with hyperthermic intraoperative intraperitoneal chemotherapy].
Legendre H; Delaunoit T; Chassaing C; Pector JC
Rev Med Brux; 2005; 26(5):439-44. PubMed ID: 16318097
[TBL] [Abstract][Full Text] [Related]
13. [Peritoneal carcinomatosis of colorectal cancer: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Königsrainer I; Beckert S; Brücher B; Zieker D; Königsrainer A
Dtsch Med Wochenschr; 2011 Sep; 136(36):1811-4. PubMed ID: 21882140
[TBL] [Abstract][Full Text] [Related]
14. Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study.
Rossi CR; Foletto M; Mocellin S; Pilati P; De SM; Deraco M; Cavaliere F; Palatini P; Guasti F; Scalerta R; Lise M
Cancer; 2002 Jan; 94(2):492-9. PubMed ID: 11900234
[TBL] [Abstract][Full Text] [Related]
15. [Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].
Vaira M; Scuderi S; Costamagna D; Barone R; Aghemo B; Mioli PR; De Simone M
Minerva Chir; 2002 Oct; 57(5):597-605. PubMed ID: 12370661
[TBL] [Abstract][Full Text] [Related]
16. Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis.
Detroz B; Laurent S; Honoré P; Blaffart F; Limet R; Meurisse M
Acta Chir Belg; 2004 Aug; 104(4):377-83. PubMed ID: 15469146
[TBL] [Abstract][Full Text] [Related]
17. [Multiorgan resection in combination with intraoperative, hyperthermic chemotherapy in recurrent fibrolamellar hepatocellular carcinoma. An individual therapeutic concept for a 21-year-old patient].
Braune C; Fangmann J; Scheumann GF; Klempnauer J
Zentralbl Chir; 2001 Apr; 126(4):318-21; discussion 322. PubMed ID: 11370396
[TBL] [Abstract][Full Text] [Related]
18. Hyperthermic intraperitoneal chemotherapy: methodology and safety considerations.
González-Moreno S; González-Bayón L; Ortega-Pérez G
Surg Oncol Clin N Am; 2012 Oct; 21(4):543-57. PubMed ID: 23021715
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal carcinomatosis: what can we do about it?
Shen P; Levine EA; Loggie BW
J Clin Oncol; 2004 Jan; 22(1):202; author reply 203. PubMed ID: 14701786
[No Abstract] [Full Text] [Related]
20. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal carcinomatosis: if at first you don't succeed...
Lambert LA; Mansfield PF
Ann Surg Oncol; 2007 Nov; 14(11):3037-9. PubMed ID: 17726635
[No Abstract] [Full Text] [Related]
[Next] [New Search]
